Free of Complexing Proteins - Enough for Low Immunogenicity of Botulinum Neurotoxin Formulations? A Comparison of Excipients

被引：0
|
作者：
Martin, Michael U. [1 ]
Frevert, Juergen [2 ]
机构：
[1] Justus Liebig Univ Giessen, D-35390 Giessen, Germany
[2] Merz Pharmaceut GmbH, Frankfurt, Germany
来源：
TOXICON | 2024年 / 237卷
关键词：
BotulinumtoxinA; Coretox; DaxibotulintoxinA-Lanm; Excipients; Immunogenicity; IncobotulinumtoxinA;
D O I：
10.1016/j.toxicon.2024.107447
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：54 / 55
页数：2
相关论文
共 50 条
  • [31] Role of Neurotoxin Associated Proteins in the Low pH Induced Structural Changes in the Botulinum Neurotoxin Complex
    Chellappan, Gowri
    Kumar, Raj
    Cai, Shuowei
    Singh, Bal Ram
    PROTEIN JOURNAL, 2014, 33 (06): : 557 - 564
  • [32] Role of Neurotoxin Associated Proteins in the Low pH Induced Structural Changes in the Botulinum Neurotoxin Complex
    Gowri Chellappan
    Raj Kumar
    Shuowei Cai
    Bal Ram Singh
    The Protein Journal, 2014, 33 : 557 - 564
  • [33] Efficacy and Safety of NT 201 (Neurotoxin Free from Complexing Proteins) in Cervical Dystonia
    Comella, Cynthia
    Jankovic, Joseph
    Truong, Daniel
    Hanschmann, Angelika
    Grafe, Susanne
    NEUROLOGY, 2009, 72 (11) : A345 - A345
  • [34] A new botulinum toxin type A free of complexing proteins for treatment of cervical dystonia
    Benecke, R
    Jost, WH
    Kanovsky, P
    Ruzicka, E
    Comes, G
    Grafe, S
    NEUROLOGY, 2005, 64 (11) : 1949 - 1951
  • [35] SUSTAINED EFFICACY OF INCOBOTULINUMTOXIN-A (XEOMIN®; BOTULINUM NEUROTOXIN TYPE-A, FREE FROM COMPLEXING PROTEINS) IN LONG-TERM TREATMENT OF CERVICAL DYSTONIA
    Dressler, D.
    Kupsch, A.
    Paus, S.
    Seitzinger, A.
    Gebhardt, B.
    EUROPEAN JOURNAL OF NEUROLOGY, 2011, 18 : 482 - 482
  • [36] NT201 (Xeomin®: botulinum neurotoxin free from complexing proteins) is efficacious and well-tolerated in upper limb spasticity of various etiologies
    Barnes, M.
    Schnitzler, A.
    Amaral e Silva, A.
    Aquilar, M.
    Lehnert-Batar, A.
    Minnasch, P.
    MOVEMENT DISORDERS, 2009, 24 : S450 - S450
  • [37] Use of an interactive voice response system by patients with blepharospasm receiving repeated injections of NT 201 (botulinum neurotoxin type A free from complexing proteins)
    Marx, M.
    Grafe, S.
    Jankovic, J.
    Comella, C.
    MOVEMENT DISORDERS, 2010, 25 (07) : S243 - S243
  • [38] Efficacy and safety of a new Botulinum Toxin Type A free of complexing proteins in the treatment of blepharospasm
    Roggenkämper, P
    Jost, WH
    Bihari, K
    Comes, G
    Grafe, S
    JOURNAL OF NEURAL TRANSMISSION, 2006, 113 (03) : 303 - 312
  • [39] Efficacy and safety of a new Botulinum Toxin Type A free of complexing proteins in the treatment of blepharospasm
    P. Roggenkämper
    W. H. Jost
    K. Bihari
    G. Comes
    S. Grafe
    Journal of Neural Transmission, 2006, 113 : 303 - 312
  • [40] NT 201, botulinum neurotoxin free from complexing proteins, Xeomin©) provided sustained efficacy and was safe in spasticity: 89 weeks long-term data
    Kanovsky, P.
    Platz, T.
    Comes, G.
    Grafe, S.
    Sassin, I.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2009, 285 : S75 - S76
12345